Eagle Bay Advisors’s Quest Diagnostics DGX Stock Holding History

Eagle Bay Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-376	Closed	-$56.7K	–	336
2024 Q4	$56.7K	Sell	376 -12	-3%	-$1.87K	0.04%	317
2024 Q3	$60.2K	Hold	388	–	–	0.02%	406
2024 Q2	$53.1K	Hold	388	–	–	0.03%	323
2024 Q1	$51.6K	Buy	388 +38	+11%	+$4.93K	0.03%	303
2023 Q4	$48.3K	Hold	350	–	–	0.03%	301
2023 Q3	$42.7K	Sell	350 -14	-4%	-$1.86K	0.02%	438
2023 Q2	$51.2K	Hold	364	–	–	0.03%	357
2023 Q1	$51.5K	Sell	364 -4	-1%	-$572	0.03%	374
2022 Q4	$57.6K	Hold	368	–	–	0.03%	348
2022 Q3	$45K	Buy	368 +17	+5%	+$2.24K	0.03%	358
2022 Q2	$46.7K	Buy	+351	New	+$47.8K	0.03%	377
2022 Q1	–	Sell	-322	Closed	-$56K	–	462
2021 Q4	$56K	Sell	322 -322	-50%	-$49K	0.04%	342
2021 Q3	$94K	Buy	644 +322	+100%	+$47.1K	0.05%	258
2021 Q2	$43K	Buy	+322	New	+$42.2K	0.03%	376

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Eagle Bay Advisors's DGX Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 376 shares — an estimated $56.7K sold.

Eagle Bay Advisors first reported a position in DGX in Q2 2021 and held it in 14 quarters. The position peaked at $94K in Q3 2021. 969 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

Eagle Bay Advisors reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
Eagle Bay Advisors sold 376 Quest Diagnostics shares in Q1 2025, an estimated $56.7K.
Eagle Bay Advisors first reported a position in Quest Diagnostics in Q2 2021 and held it in 14 quarters.
Eagle Bay Advisors's Quest Diagnostics position peaked at $94K in Q3 2021.
969 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.